DAAT may work where DOT model fell short. Good results for drugs issued by methadone clinics.
While there are some similarities between HIV and tuberculosis treatments, it's the difference in treatment regimens, duration, and end results that have made HIV clinicians and other somewhat hesitant to use the directly observed treatment strategy, which has been so successful in treating TB, with HIV patients. However, the drawbacks to modeling HIV treatment after DOT have been that unlike TB medication, HIV medication always is prescribed daily and that HIV is incurable so medications must continue for the patient's lifetime, rather than for the six months that a typical TB patient might receive treatment.